Daito Pharmaceutical Co., Ltd.'s total assets for Q1 2025 were ¥78.84B, an increase of 1.07% from the previous quarter. JP:4577 total liabilities were ¥26.63B for the fiscal quarter, a 2.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.